Corindus to Feature CorPath® GRX System at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) announced today that it will be participating in the SCAI 2017 Scientific Sessions to be held May 10-13 in New Orleans, LA. Robotic-assisted percutaneous coronary intervention (PCI) will be featured throughout the conference, including in the exhibit hall, presentations, and during a lunch symposium.

SCAI attendees are invited to register for the educational lunch symposium entitled “The Next Generation of Cath Lab Robotics” sponsored by Corindus on Friday, May 12 from 12:15 – 1:15pm. The symposium, chaired by Ehtisham Mahmud, MD, FSCAI of UC San Diego School of Medicine, will also feature faculty and key robotic physicians Ryan Madder, MD, Frederick Meijer Heart & Vascular Institute, Spectrum Health, and Paul Campbell, MD, Carolinas HealthCare System NorthEast. Audience Q&A and discussion will follow the symposium presentations.

Symposium Chairman Ehtisham Mahmud, MD, stated, “I look forward to sharing how robotic PCI can be incorporated to the contemporary practice of interventional cardiology. Recent advancements in the CorPath technology platform have been transformational and I am enthusiastic about the future of robotics in the treatment of complex coronary disease.”

The symposium will feature the following topics:

  • “The Field of Vascular Robotics” with Ehtisham Mahmud, MD
  • “Building a Robotic Program: My First 100 Cases” with Ryan Madder, MD
  • “Robotic Precision” with Paul Campbell, MD
  • “Robotics First: Capabilities of Robotics in Complex Intervention Cases” with Ehtisham Mahmud, MD

Space for the lunch symposium is limited; registration is available at www.corindus.com/SCAI2017.

During the conference, Dr. Mahmud will also present study data from the PRECISION Registry as a Late Breaking Clinical Trial.

In addition to educational opportunities to learn more about robotics, the CorPath GRX System will be on display in Corindus’ Booth 304. To schedule a hands-on demonstration of robotic-assisted PCI with an advanced simulator, please visit www.corindus.com/SCAI2017.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.